Wir benötigen Ihre Einwilligung zur Verwendung der einzelnen Daten, damit Sie unter anderem Informationen zu Ihren Interessen einsehen können. Klicken Sie auf "OK", um Ihre Zustimmung zu erteilen.
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)
Automatische name übersetzung:
Standard Test Method for Beurteilung der intravaskulären Medical Device Materials auf partielle Thromboplastinzeit (PTT)
NORM herausgegeben am 1.6.2010
Bezeichnung normen: ASTM F2382-04(2010)
Anmerkung: UNGÜLTIG
Ausgabedatum normen: 1.6.2010
SKU: NS-53724
Zahl der Seiten: 3
Gewicht ca.: 9 g (0.02 Pfund)
Land: Amerikanische technische Norm
Kategorie: Technische Normen ASTM
Keywords:
blood coagulation, blood compatibility, partial thromboplastin time, PTT, Medical devices/equipment, Partial Thromboplastin Time (PTT), Blood coagulation, Blood compatibility, ICS Number Code 11.100 (Laboratory medicine), 11.100.30 (Analysis of blood and urine)
Significance and Use | ||||
The purpose of this test method is to determine the time citrated plasma exposed to medical materials takes to form a clot when exposed to a suspension of phospholipid particles and calcium chloride. In this test method, the test article is the activator. The PTT assay is a general screening test for medical material’s ability to activate the intrinsic coagulation pathway. Material samples that show a shortened PTT are activators of the intrinsic coagulation pathway. Test samples that show a shortened PTT are activators of the intrinsic coagulation pathway. The results are reported as a percent of the negative control. The test article, reference materials, and controls are exposed to human plasma. The plasma is tested on a coagulation device. Each sample tube is assayed in duplicate. |
||||
1. Scope | ||||
1.1 This test method covers the screening of cardiovascular device materials for their ability to induce blood coagulation via the intrinsic coagulation pathway. This assay should be part of the hemocompatibility evaluation for devices and materials contacting human blood, as per ANSI/AAMI/ISO 10993-4. 1.2 All safety policies and practices shall be observed during the performance of this test method. 1.3 All plasma and any materials that had contact with plasma will be bagged in a biohazard bag, properly labeled with the contents, and disposed by appropriate means. The plasma should be handled at the Biosafety Level 2 as recommended in the Centers for Disease Control/National Institutes of Health Manual Biosafety in Microbiological Laboratories. 1.4 The normal pooled human plasma must have tested negative for Hepatitis B (HBV) or Human Immunodeficiency (HIV) viruses. The plasmas should be treated like any patient plasma using universal precautions. The plasma should be handled at the Biosafety Level 2 as recommended in the Centers for Disease Control/National Institutes of Health Manual Biosafety in Microbiological Laboratories. 1.5 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. |
||||
2. Referenced Documents | ||||
|
Historisch
1.6.2013
Historisch
1.9.2011
Historisch
1.12.2011
Historisch
1.11.2013
Historisch
15.2.2013
Letzte Aktualisierung: 2024-11-22 (Zahl der Positionen: 2 206 568)
© Copyright 2024 NORMSERVIS s.r.o.